Jan-Paul Esser

977 total citations · 1 hit paper
6 papers, 751 citations indexed

About

Jan-Paul Esser is a scholar working on Oncology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jan-Paul Esser has authored 6 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 3 papers in Epidemiology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jan-Paul Esser's work include Neuroendocrine Tumor Research Advances (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Lung Cancer Research Studies (2 papers). Jan-Paul Esser is often cited by papers focused on Neuroendocrine Tumor Research Advances (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Lung Cancer Research Studies (2 papers). Jan-Paul Esser collaborates with scholars based in Netherlands. Jan-Paul Esser's co-authors include Jaap J.M. Teunissen, Dik J. Kwekkeboom, Willem H. Bakker, P.P.M. Kooij, Eric P. Krenning, Wouter W. de Herder, Casper H.J. van Eijck, Richard A. Feelders, E. P. Krenning and Marion de Jong and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Nuclear Medicine and Molecular Imaging and Best Practice & Research Clinical Gastroenterology.

In The Last Decade

Jan-Paul Esser

6 papers receiving 719 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Radiolabeled Somatostatin Analog [¹⁷⁷Lu-DOTA⁰,Tyr³]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors

2005 517 citations Dik J. Kwekkeboom, Jaap J.M. Teunissen et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan-Paul Esser Netherlands	5	606	485	422	242	55	6	751
WH Bakker Netherlands	9	583 1.0×	455 0.9×	371 0.9×	327 1.4×	76 1.4×	16	790
Nicolas Marincek Switzerland	10	792 1.3×	662 1.4×	546 1.3×	217 0.9×	61 1.1×	11	944
Gregory D. Espenan United States	10	408 0.7×	357 0.7×	287 0.7×	157 0.6×	56 1.0×	16	574
Maribel Lopera Sierra United States	9	514 0.8×	452 0.9×	353 0.8×	159 0.7×	44 0.8×	24	640
Tilmann Schumacher Switzerland	4	432 0.7×	358 0.7×	271 0.6×	212 0.9×	109 2.0×	6	601
Esther I. van Vliet Netherlands	7	379 0.6×	338 0.7×	275 0.7×	139 0.6×	47 0.9×	9	496
Miklos Pless Switzerland	6	358 0.6×	329 0.7×	305 0.7×	174 0.7×	70 1.3×	7	559
Anna Sowa‐Staszczak Poland	16	685 1.1×	555 1.1×	444 1.1×	221 0.9×	73 1.3×	70	970
Beth Chasen United States	11	369 0.6×	343 0.7×	261 0.6×	122 0.5×	63 1.1×	19	557
Hendrik Bergsma Netherlands	6	380 0.6×	379 0.8×	246 0.6×	241 1.0×	87 1.6×	9	554

Countries citing papers authored by Jan-Paul Esser

Since Specialization

Citations

This map shows the geographic impact of Jan-Paul Esser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan-Paul Esser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan-Paul Esser more than expected).

Fields of papers citing papers by Jan-Paul Esser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan-Paul Esser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan-Paul Esser. The network helps show where Jan-Paul Esser may publish in the future.

Co-authorship network of co-authors of Jan-Paul Esser

This figure shows the co-authorship network connecting the top 25 collaborators of Jan-Paul Esser. A scholar is included among the top collaborators of Jan-Paul Esser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan-Paul Esser. Jan-Paul Esser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Scholtens, Asbjørn M., et al.. (2020). Suppression of myocardial glucose metabolism in FDG PET/CT: impact of dose variation in heparin bolus pre-administration. European Journal of Nuclear Medicine and Molecular Imaging. 47(11). 2698–2702. 21 indexed citations

2.

Esser, Jan-Paul, E. P. Krenning, Jaap J.M. Teunissen, et al.. (2006). Comparison of [177Lu-DOTA0,Tyr3]octreotate and [177Lu-DOTA0,Tyr3]octreotide: which peptide is preferable for PRRT?. European Journal of Nuclear Medicine and Molecular Imaging. 33(11). 1346–1351. 132 indexed citations

3.

Teunissen, Jaap J.M., Dik J. Kwekkeboom, Marion de Jong, et al.. (2005). Peptide receptor radionuclide therapy. Best Practice & Research Clinical Gastroenterology. 19(4). 595–616. 66 indexed citations

4.

Kwekkeboom, Dik J., Jaap J.M. Teunissen, Willem H. Bakker, et al.. (2005). Radiolabeled Somatostatin Analog [¹⁷⁷Lu-DOTA⁰,Tyr³]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors. Journal of Clinical Oncology. 23(12). 2754–2762. 517 indexed citations breakdown →

5.

Esser, Jan-Paul, H.Y. Oei, Hein G. de Bruin, & Eric P. Krenning. (2004). Liver and Vertebral Uptake of Tc-99m Macroaggregated Albumin (MAA). Clinical Nuclear Medicine. 29(12). 793–794. 13 indexed citations

6.

Esser, Jan-Paul, H.Y. Oei, Dik J. Kwekkeboom, & Eric P. Krenning. (2003). Diffuse Lung and Stomach Uptake of Tc-99m Oxidronate (HDP). Clinical Nuclear Medicine. 28(10). 845–846. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact